|
|
Article: Neurocrine Biosciences to Present Phase III Indiplon Modified Release Results for Sleep Maintenance in Patients With Chronic Insomnia at the UBS Global Life Sciences Conference; The Presentation Will Be Webcast Thursday, September 25, 2003.
- Article from:
- PR Newswire
- Article date:
- September 23, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Neurocrine Biosciences, Inc. announced today that the Company will webcast their presentation at the UBS Global Life Sciences Conference on Thursday, September 25, 2003 at 11:00 AM Eastern Daylight Time; 8:00 AM Pacific Daylight Time. Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will present the Company's first Phase III results with its modified release formulation of indiplon. The webcast can be accessed on Neurocrine's website at http://www.neurocrine.com/ or alternatively via the link provided by UBS at http://www.ibb.ubs.com/. On the UBS website, click on the Conferences link in the middle of the page and follow the link for Webcast ...